|3.15||0.00 / 0.00%|
Data as of 3:59pm ET
|3.12||-0.03 / -0.95%|
The 3 analysts offering 12-month price forecasts for Catalyst Pharmaceutical Partners Inc have a median target of 5.00, with a high estimate of 13.00 and a low estimate of 4.00. The median estimate represents a +58.73% increase from the last price of 3.15.
The current consensus among 3 polled investment analysts is to Buy stock in Catalyst Pharmaceutical Partners Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.